Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-09-25
2007-09-25
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S199100, C435S091100, C435S325000, C435S235100
Reexamination Certificate
active
10436706
ABSTRACT:
The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
REFERENCES:
patent: 6302685 (2001-10-01), Lobel et al.
Morgan et al., “Insulin-like growth factor II receptor as a multifunctional binding protein,” Nature, vol. 329, pp. 301-307. Sep. 24, 1987.
O'Gorman et al., “Decreased Insuline-like Growth Factor-II/Mannose 6-Phosphate Receptor Expression Enhances Tumorigenicity in JEG-3 Cells,” Cancer Research, vol. 59, pp. 5692-5694. Nov. 15, 1999.
Pohlmann et al., “Cloning of a cDNA encoding the human cation-dependent mannose 6-phosphate-specific receptor,” Proc. Natl. Acad. Sci. USA, vol. 84, pp. 5575-5579. Aug. 1987.
Arvin, A.M., et al., Humoral and cellular immunity toVaricella-zostervirus glycoprotein, gpl, and to a non-glycosulated protein p170, in strain 2 guinea pigs. J. Gen. Virol., 1987, 68: p. 2449-2454.
Cohen, J., et al., Chronic uveitis in guinea pigs infected withVaricella-zostervirus expressingE. colibeta-galactosidase. J. Infect. Dis., 1998, 177: p. 293-300.
Cohrs RJ., Barbour M. and Gilden DH.,Varicella-zostervirus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62 and 63 in a cDNA library enriched for VZV RNA. J. Virol. 1996 70(5): 2789-2796.
David, D.S., et al., VisceralVaricella-zosterafter bone marrow transplantation: report of a case series and review of the literature. Am. J. Gasteroenterol., 1998, 93: p. 810-813.
Fiorica-Howells, E., Wade, P.R. and Gershon, M.D., Serotonin-induced increase in cAMP in ganglia isolated from the myenteric plexus of the guinea pig small intestine: mediation by a novel 5-HT receptor. Synapse, 1993, 13: p. 333-349.
Furness, J. B., et al., Intrinsic primary afferent neurons of the intestine. Prog. Neurobiol., 1998, 54(1): p. 1-18.
Gershon, M.D., Kirchgessner, A.L. and Wade, P.R., Functional anatomy of the enteric nervous system, in Physiology of the gastrointestinal tract. Third Edition, Johnson, L.R., et al., Editors. 1994, Raven Press: New York. p. 381-422.
Gilden, D.H., et al., Neurologic complications of the reactivation ofVaricella-zostervirus. N. Engl. J. Med., 2000. 342: p. 635-645.
Kennedy, P., Grinfield, E. and Gow, J.W., LatentVaricella-zostervirus in human dorsal root ganglia. Virology, 1999, 258: p. 451-454.
Kennedy PG., Grinfeld E. and Gow, J.W., LatentVaricella-zostervirus is located predominantly in neuron in human trigeminal ganglia. Proc Natl Acad Sci USA 1998 95(8): 4658-4662.
Kennedy PG., Grinfeld E. and Bell JE.,Varicella-zostervirus gene expression in latently infected and explanted human ganglia. J. Virol. 2000 74(24): 11893-11898.
Kirchgessner, A.L., Tamir, H and Gershon, M.D., Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J. Neurosci., 1992, 12: p. 235-249.
Kinchington PR., Fite K. and Turse SE., Nuclear accumulation of IE 62, theVaricella-zostervirus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading fram 66 protein kinase. J. Virol. 2000, 74(5): 2265-2277.
Kunze, W.A.A. and Furness, J.B., The enteric nervous system and regulation of intestinal motility. Annu. Rev. Physiol., 1999, 61: p. 117-142.
Kunze, W. A., Bornstein, J.C. and Furness, J.B., Identification of sensory nerve cells in a peripheral organ (the intestine) of a mammal. Neuroscience, 1995, 66: p. 1-4.
Lowry, P. W., et al., Immunity in strain 2 guinea pigs inoculated with vaccinia virus recombinants expressingVaricella-zostervirus glycoproteins I, IV,V, or the protein product of the immediate early gene 62. J. Gen Virol, 73: p. 811-819.
Lowry, P. W., et al., Investigation of the pathogenesis ofVaricella-zostervirus infection in guinea pigs by using polymerase chain reaction. J. Infect. Dis., 1993, 167: p. 78-83.
Lungu, O. and Annunziato, P., VZV: Latency and reactivation, in Contributions to microbiology:Varicella-zostervirus: molecular biology, pathogenesis, and clinical aspects, Wolff, M.H., Schunemann, W. and Schmidt, A., Editors. 1999, Karger: Basel. p. 61-75.
Lungu O., et al., Aberrant intracellular localization ofVaricella-zostervirus regulatory proteins during latency. Proc Natl Acad Sci USA 1998, 95(12): 7080-7085.
Matsunaga Y., Yamanishi K. and Takahashi M., Experimental infection and immune response of guinea pigs withVaricella-zostervirus. Infect Immun. 1982, 37(2): p. 407-412.
Myers, M., Duer, H.L. and Haulser, C.K., Experimental infection of guinea pigs withVaricella-zostervirus. J. Infect Dis, 1980, 142: p. 414-420.
Myers, M., Stanberry, L. and Edmond, B.,Varicella-zostervirus infection of strain 2 guinea pigs. J. Infect Dis, 1985, 151: p. 106-113.
Myers, M.G., Connelly, B and Stanberry, L.R., Varicella in hairless guinea pigs. J. Infect Dis, 1991, 163:p. 746-751.
Myers, M. and Stanberry, L., Drug testing for activity againstVaricella-zostervirus in hairless guinea pigs. Antiviral Res., 1991, 15: p. 341-344.
Pan, H. and Gershon MD., Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J. Neurosci. 2000, 20(9): 3295-3309.
Pompolo, S. and Furness, J.B., Ultrastructure and synaptic relationships of calbindin-reactive, Dogiel type II neurons, in the myenteric ganglia of guinea-pig small intestine. J. Neurocytol., 1988. 17:p. 771-782.
Pui, J.C., et al., Demonstration ofVaricella-zostervirus infection in the muscularis propria and myenteric plexi of the colon in an HIV-positive patient with herpes zoster and small bowel pseudo-obstruction (Ogilivie's syndrome). Am. J. Gastroenterol., 2001, 96(5): p. 1627-1630.
Rogers, S. Y., Irving, W. and Russell, N.H., VisceralVaricella zosterinfection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transpl., 1995. 15: p. 805-807.
Sabella, C., et al., Immunization with the immediate-early tegument protein (open reading frame 62) ofVaricella-zosterprotects guinea pigs against virus challenge. J. Virol. 1993, 67(12): 7673-7676.
Sato, H., et al., Immune response toVaricella-zostervirus glycoproteins in guinea pigs infected with Oka varicella vaccine. Vaccine, 1998, 16: p. 1263-1269.
Schafer, K. H., et al., A new method for the isolation of myenteric plexus from the newborn rat gastrointestinal tract. Brain Res Protoc, 1997, 1(2): p. 109-113.
Schiller, G. L., et al., Abdominal presentation ofVaricella-zosterinfection in recipients of allogenetic bone marrow transplantation Bone Marrow Transpl., 1991, 7: p. 489-491.
Stemmer, S. M., et al., Fatal noncutaneous visceral infection withVaricella-zostervirus in a patent with lymphoma after autologous bone marrow transplantation. Clin Infect Dis, 1993, 16: p. 497-499.
Takahashi, M., et al., Live vaccine used to prevent the spread of varicella in children in hospital. Lancet, 1974, 2: p. 1288-1290.
Tribble, D. R., Church, P. and Frame, J. N., Gastrointestinal visceral motor complications of dermatomal herpes zoster: report of 2 cases and a review Clin. Infect. Dis, 1993, 17: p. 431-436.
Xia, Y., Fertel, R.H. and Wood, J.D., Stimulation of formation of cAMP by 5-hydroxytryptamine in myenteric ganglia isolated from guinea pig small intestine. Life Sci., 1994, 55: p. 685-692.
Zhai J., et al., Inward currents in neurons from newborn guinea pig intestin: mediation by 5-hydroxytryptamine type 3 receptors. J. Pharmacol Exp. Ther. 1999, 291 (1): 374-382.
Chen Jason J.
Gershon Anne A.
Gershon Michael D.
Silverstein Saul
Zhu Zhenglun
Salimi Ali R.
The Trustees of Columbia University in the City of New York
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Genetically engineered cell lines and systems for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically engineered cell lines and systems for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered cell lines and systems for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3746447